Citadel Advisors »

Hcw Biologics shares owned by Citadel Advisors

Quarter-by-quarter ownership of Hcw Biologics (HCWB) shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Hcw Biologics

Tip: Access up to 7 years of quarterly data

All positions including Hcw Biologics held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Hcw Biologics by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2026-03-31 $9.4k 26k 0.36
2025-12-31 $22k 22k 0.97

More positions owned by Citadel Advisors

State Str Spdr S&p 500 Etf T Tr Unit Call Option (SPY)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
NVIDIA Corporation Call Option (NVDA)
Tesla Motors Call Option (TSLA)
Spdr Gold Tr Gold Shs Call Option (GLD)
Apple Call Option (AAPL)
Meta Platforms Cl A Call Option (META)
Microsoft Corporation Call Option (MSFT)
Amazon Call Option (AMZN)
Micron Technology Call Option (MU)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Netflix Call Option (NFLX)
Broadcom Call Option (AVGO)
Alphabet Cap Stk Cl C Call Option (GOOG)

View all positions for Citadel Advisors

Top funds holding Hcw Biologics

Hrt Financial
Geode Capital Management
Citadel Advisors
Susquehanna International
Vanguard Group
Jane Street
Vanguard Capital Management
Citigroup
Golden State Wealth Management
UBS Group
Tower Research Capital
Vanguard Fiduciary Trust
Wells Fargo & Company
Advisor Group Holdings
Northwestern Mutual Wealth Management Company

View all funds holding Hcw Biologics